Keystone Investment Trust plc
Interim Management Statement
for the three months ended 30 June 2013
Material Events
No material events occurred in the period.
The Company issued 75,000 ordinary shares in July 2013 at an average price of
1707p.
Dividends
In the period, an interim dividend of 18p per ordinary share was paid on 28
June 2013 to shareholders on the register on 31 May 2013.
Performance - Total Return
3 Months 1 Year 3 Years 5 Years
Share Price 5.5% 34.1% 70.3% 93.8%
Net Asset Value 1.7% 28.7% 63.1% 72.4%
FTSE All-Share Index -1.7% 17.9% 43.5% 38.2%
Source: Thomson Reuters Datastream
Share Price and Discount
At For the Three Months Ended 30 June 2013
30-Jun-13 High Low Average
Share Price (pence) 1561.00 1645.00 1490.00 1571.90
Discount (debt at par) 3.7%
Discount (debt at fair 0.5%
value)
Source: Thomson Reuters Datastream
Assets and Gearing
30-Jun-13
Total Gross Assets (£m) 249.8
of which cash and Certificates of Deposit(£ 11.9
m)
Borrowings (£m) 31.9
Cum Income Net Asset Value (pence) 1621.2
Gross Gearing 14.6%
Net Gearing 9.2%
`Gross Gearing' reflects the amount of gross borrowings in use by a company and
takes no accounts of any cash balances. It is based on gross borrowings as a
percentage of shareholders' funds.
`Net Gearing' reflects the amount of net borrowings invested, i.e borrowings
less cash and bond holdings. It is based on net borrowings as a percentage of
shareholders' funds.
The Company's structured debt is provided by 250,000 5% cumulative preference
shares of £1 each and the following debentures totalling £32 million:
- £7,000,000 7.75% debenture stock 2020
- £24,968,300 6.5% debenture stock 2023
Sector Breakdown of Portfolio (excluding Cash and Certificates of Deposit)
30-Jun-13
Healthcare 21.6%
Financials 20.3%
Consumer Goods 16.1%
Industrials 15.1%
Consumer Services 12.5%
Telecommunications 9.3%
Utilities 4.9%
Basic Materials 0.2%
100.0%
Top Ten Holdings
Investments % of Portfolio
BT 6.0%
Reynolds American - US Common Stock 4.6%
Imperial Tobacco 4.5%
AstraZeneca 4.5%
British American Tobacco 4.3%
Roche - Swiss Common Stock 4.2%
Novartis - Swiss Common Stock 4.2%
Thomas Cook 3.9%
GlaxoSmithKline 3.7%
BAE Systems 3.2%
All ordinary shares unless otherwise stated
Changes to Share Capital
Ordinary Shares of 50p each
Issued
As at 31 Mar 2013 13,443,799
Shares bought back 0
Shares issued 0
As at 30 Jun 2013 13,443,799
The Company has authority to buy back shares for cancellation and to issue new
shares (disapplying pre-emption rights), in each case within specified limits.
The Company expects to renew these authorities each year.
Administration
The Company's Ordinary shares are listed on the London Stock Exchange and the
price is published in the Times and the Financial Times under `Investment
Companies' and in the Daily Telegraph under `Investment Trusts'.
The Company's net asset value is calculated on a daily basis and can be viewed
on the London Stock Exchange website at www.londonstockexchange.com
Further information can be obtained from Invesco Perpetual as follows:
Free Investor Helpline: 0800 085 8677
Internet address: www.invescoperpetual.co.uk/investmenttrusts
The information provided in this statement should not be considered as a
financial promotion.
Interim management statements are expected to be published in January and July
each year.
Invesco Asset Management Limited
For and on behalf of
The Board of Keystone Investment Trust plc
25 July 2013
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.